Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Nationwide, the prevalence of the hepatitis C virus (HCV) has risen in recent years. At least 90% of infected persons must be treated to achieve global elimination targets. The current study aimed to explore barriers to, and facilitators of, direct-acting antiviral (DAA) HCV treatment uptake amongst pregnant and early-parenting women undergoing comprehensive substance use treatment. Twenty participants with documented HCV antibody positivity were recruited from two substance use treatment centers in central Kentucky. Semi-structured interviews were conducted to explore knowledge about HCV, previous experiences, and intentions to seek care. Themes were extracted using an inductive analytical approach. Most participants were aware of the dangers posed by HCV infection. However, there was a high degree of misinformation about transmission mechanisms and treatment eligibility requirements. Low priority for HCV treatment also surfaced as a barrier to treatment uptake. Participants reported being unable to seek care due to time and resource limitations in the presence of a highly demanding treatment process. Findings from the current study suggest that more work is needed to eliminate residual barriers that limit access to HCV treatment among pregnant and early-parenting women in treatment for substance use disorder.

Details

Title
Reported Barriers to Hepatitis C Treatment among Pregnant and Early-Parenting Mothers Undergoing Substance Use Disorder Treatment in One U.S. State
Author
Ayooluwatomiwa, Deborah Adekunle 1   VIAFID ORCID Logo  ; Harp, Kathi L 2   VIAFID ORCID Logo  ; Al-Abdali, Zaynab G 2 ; Critchfield, Agatha S 3 ; Barnhart, Sheila 4 ; Winter, Kathleen T 2 

 Division of Internal Medicine, St. Luke’s Hospital, Chesterfield, MO 63017, USA; College of Public Health, University of Kentucky, Lexington, KY 40508, USA; [email protected] (K.L.H.); [email protected] (Z.G.A.-A.); [email protected] (K.T.W.) 
 College of Public Health, University of Kentucky, Lexington, KY 40508, USA; [email protected] (K.L.H.); [email protected] (Z.G.A.-A.); [email protected] (K.T.W.) 
 Baptist Health Medical Group, Lexington, KY 40503, USA; [email protected] 
 College of Social Work, University of Kentucky, Lexington, KY 40508, USA; [email protected] 
First page
1
Publication year
2022
Publication date
2022
Publisher
MDPI AG
ISSN
20367430
e-ISSN
20367449
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2632745428
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.